Search Results

1

Sequence-dependent synergistic effect of aumolertinib-pemetrexed combined therapy on EGFR-mutant non-small-cell lung carcinoma with pre-clinical and clinical evidence

by Ao, L., Cui, J., Fang, S., Gao, Y., Jia, W., Liu, J., Shan, Y., Wang, G., Zhang, J., Zhang, K., Zhou, F.
Published 2022

Call Number: Loading...
Located: Loading...

View Fulltext in Publisher

Article
2

miR-6077 promotes cisplatin/pemetrexed resistance in lung adenocarcinoma via CDKN1A/cell cycle arrest and KEAP1/ferroptosis pathways

by Besskaya, V., Bi, G., Bian, Y., Chen, Z., Huang, Y., Jin, X., Liang, J., Lu, T., Tan, L., Wang, Q., Zhan, C., Zhang, H., Zhao, M., Zheng, Y.
Published 2022

Call Number: Loading...
Located: Loading...

View Fulltext in Publisher

Article
3

Key use cases for artificial intelligence to reduce the frequency of adverse drug events: a scoping review

by Amato, M.G, Bain, P.A, Bates, D.W, Co, Z., Dulgarian, S., Edrees, H., Foer, D., Kuznetsova, M., Purcell Jackson, G., Rhee, K., Seger, D.L, Simona, A., Song, W., Syrowatka, A.
Published 2022

Call Number: Loading...
Located: Loading...

View Fulltext in Publisher

Article
4

Critical parameters for particle-based pulmonary delivery of chemotherapeutics

by Abdul Rahman, N., Abu Kasim, N.H, Dabbagh, A., Wong, T.W, Yeong, C.H
Published 2018

Call Number: Loading...
Located: Loading...

View Fulltext in Publisher
View in Scopus

Article
5

Review of Pharmacoeconomic Studies in Russian Cancer Research: An Outside View

by Djalalov, S., Djalalova, D., Hoch, J.S, Krahn, M., Matveev, N.
Published 2019

Call Number: Loading...
Located: Loading...

View Fulltext in Publisher

Article